Antiplatelet Agents in Patients Undergoing Percutaneous Coronary Intervention: How Many and How Much?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.5, 2005-01, pp. : 307-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D. Keating Gillian M. Wellington Keri

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

By Hamdalla Hussam Moliterno David J

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1669-1673

Informa Healthcare

Access to resources Recommend Favorite

Anemia in Patients Undergoing Percutaneous Coronary Intervention: Current Issues and Future Directions

By Wang Tracy Y. Rao Sunil V.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 496-510

Bentham Science Publishers

Access to resources Recommend Favorite